Where does Nano Vation Therapeutics Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nano Vation Therapeutics Inc. ranks #41,856 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nano Vation Therapeutics Inc. hold?

Nano Vation Therapeutics Inc. holds 6 US utility patents granted between 2024 and 2025, spanning 10 technology areas.

What is Nano Vation Therapeutics Inc.'s Innovation Score?

Nano Vation Therapeutics Inc. has an Innovation Score of 48.1 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Nano Vation Therapeutics Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Nano Vation Therapeutics Inc..

What does claim depth mean for Nano Vation Therapeutics Inc.'s patents?

Nano Vation Therapeutics Inc.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nano Vation Therapeutics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nano Vation Therapeutics Inc.

Q: What technology areas does Nano Vation Therapeutics Inc. focus on?

Nano Vation Therapeutics Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents, ranking #1,801 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 10 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nano ranks #41,856 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 10 technology areas.

#41,856
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.1/100): 17.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R41856 · Foreign Corporation #41,856 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #41,856/49,997
PHOTO-FINISH Nano Evaporative
CPC-FOCUS C12N · 10 areas
INNOV-PAR 48.1/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Nano Evaporative Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nano’s 48.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (14%) Velocity 20.0 pts (42%) Breadth 11.2 pts (23%) Claim depth 10.2 pts (21%)

Qualcomm Incorporated · highest

85
Nano Vation… · this assignee

48
3D Lighting… · lowest

7

What this shows Nano's Innovation Score is 48.1/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nano?

Each dot is one of Nano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nano’s own 17.0 claims/patent is ABOVE the 16.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nano vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nano's grants concentrate

Nano Vation Therapeutics Inc. is a focused PatentsView assignee: 10 CPC subclasses with 83.3% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). By volume, Nano sits between Nano Evaporative Technologies, Inc. and Nanofilm Technologies International Limited.

Nano's three-year grant acceleration

Nano Vation Therapeutics Inc. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nano Evaporative

6
Nano Hesgarsazan…

6
Nano Safe Coating…

6
Nano Shield Techn…

6
Nanoracks

6
Nanosurgery Techn…

6
Nanovault Medical

6
Nanofilm Internat…

6
Nano Vation Thera… ◀

6

What this shows Nano holds 6 patents at rank #41,940, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nano

By rank, the assignees closest to #41,940 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Nano's primary technology class.

Nano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Nano Vation Therapeutics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	4	66.7%
2025partial year	2	33.3%

Which technologies does Nano Vation Therapeutics Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61B - DIAGNOSIS; SURGERY; Identification 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07D - Heterocyclic Compounds 1

C07C - Acyclic OR Carbocyclic Compounds 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nano Vation Therapeutics Inc.'s patent record in context - here's where to go next.

Nano Vation Therapeutics Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 83.3% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #41,856 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nano Vation Therapeutics Inc. against Nano Evaporative Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.